We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Exceptionally Detailed Images Made Possible with New Imaging Modality

By HospiMedica International staff writers
Posted on 06 Oct 2008
New technology will enable extremely detailed images to be made of the smallest structures of the human body. More...
The goal is to detect the risk or start of an illness at a very early stage in the brain, or the heart, and cancer research. The new equipment will be the only magnetic resonance imaging (MRI) device of the modern 7-Tesla generation in the world, in which a metrology institute is also involved.

MRI units, which use a magnetic field of 7 Tesla, have not yet been in operation in hospitals and clinics, but have solely served research. For the first time, cardiovascular research performed on such a device is now also to play an important role. The magnetic resonance tomograph, costing approximately EUR 7 million and weighing 35 tons, was delivered to its new location, the Experimental and Clinical Research Center (ECRC) of the Max Delbrück Center (MDC) for Molecular Medicine in Berlin-Buch, Germany, on September 11, 2008.

In contrast to the 1.5 and 3 Tesla devices, which have largely been the standard to date, its higher magnetic field will provide sharper images and better insights into the smallest structures of the human body.

Most significantly, heart research by MRI technology is viewed as very difficult. As such, a demanding task will be waiting for scientists, including those from the Physikalisch-Technische Bundesanstalt (PTB; Braunschweig, Germany) from January 2009, when the device has been fully installed: as the partner dealing with physics and technical issues in the joint project, they are responsible for making the unique potential of this technology useful for applications in clinics.

Moreover the PTB researchers will find the ideal conditions to advance its work on patient safety in high-field MRI units and on the development of new concepts in MR imaging. The other partners in the project, in addition to the Max Delbrück Center and the PTB, are Siemens Healthcare (Erlangen, Germany), the developers of the 7 Tesla device, and the Charité University Hospital (Berlin, Germany).

Related Links:
Max Delbrück Center
Physikalisch-Technische Bundesanstalt
Siemens Healthcare



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Temperature Monitor
ThermoScan Temperature Monitoring Unit
Cardiograph Device
PageWriter TC35
Spirometry & Oximetry Software
MIR Spiro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.